리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 07월
페이지 정보:영문 479 Pages
라이선스 & 가격 (부가세 별도)
한글목차
산후 우울증 치료제 세계 시장은 2030년까지 14억 달러에 달할 전망
2024년에 8억 9,490만 달러로 추정되는 산후 우울증 치료제 세계 시장은 분석 기간 2024-2030년에 CAGR 7.8%로 성장하여 2030년에는 14억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 산후 불안은 CAGR 6.1%를 기록하며 분석 기간 종료시에는 3억 50만 달러에 달할 것으로 예측됩니다. 산후 우울감 분야의 성장률은 분석 기간 동안 CAGR 5.7%로 추정됩니다.
미국 시장은 2억 4,380만 달러로 추정, 중국은 CAGR 11.8%로 성장 예측
미국의 산후 우울증 치료제 시장은 2024년에 2억 4,380만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 11.8%로 성장하여 2030년에는 2억 9,420만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 4.1%와 7.4%로 예측됩니다. 유럽에서는 독일이 CAGR 5.1%로 성장할 것으로 예측됩니다.
세계의 산후 우울증 치료제 시장 - 주요 동향과 촉진요인 정리
산후 우울증 치료의 전망을 형성하는 최신 혁신은 무엇일까?
산후 우울증(PPD) 치료제 시장은 최근 의약품 연구의 발전과 산모의 정신건강에 대한 인식이 높아짐에 따라 큰 변화를 겪고 있습니다. 선택적 세로토닌 재흡수 억제제(SSRI)와 세로토닌 노르에피네프린 재흡수 억제제(SNRI)와 같은 기존의 항우울제는 오랫동안 표준 약물이었습니다. 그러나 최근 브렉사놀론(Zulesso)이나 주라놀론과 같은 속효성 약물이 승인되면서 치료 접근 방식에 패러다임의 변화가 일어나고 있습니다. 효과가 나타나기까지 몇 주가 걸리는 기존 항우울제와는 달리, 이 새로운 약물들은 몇 시간에서 며칠 내에 완화를 가져와 심각한 PPD 환자들의 즉각적인 해결책에 대한 긴급한 요구에 부응하고 있습니다.
또한, 기존의 항우울제와는 다른 기전을 가진 감마 아미노부티르산(GABA) 수용체를 표적으로 하는 신경스테로이드 기반 약물의 역할에 대한 관심도 높아지고 있습니다. 연구자들은 또한 유전자 및 바이오마커에 기반한 데이터를 활용하여 개별 환자의 프로필에 따라 약물 치료를 조정하는 맞춤형 의료 접근법도 모색하고 있습니다. 원격의료와 디지털 건강 도구의 사용 확대는 이러한 혁신적인 치료법에 대한 접근성을 더욱 향상시켜 PPD 치료를 보다 효율적이고 환자 중심으로 개선하고 있습니다.
시장 동향과 소비자 의식은 어떻게 수요를 형성하고 있는가?
산후 우울증 치료제에 대한 수요는 산모의 정신건강 문제에 대한 인식이 높아지고 의료 정책이 발전함에 따라 전 세계적으로 증가하고 있습니다. 전 세계 정부와 의료 기관은 PPD에 대한 편견을 없애고 환자들이 의료적 개입을 받도록 장려하는 인식 개선 캠페인에 투자하고 있습니다. 정신건강 치료에 대한 보험급여 확대 정책도 PPD 약물 처방률을 높이는 데 중요한 역할을 하고 있습니다.
또한 제약 업계에서는 새로운 제제 개발을 위한 공동 연구가 급증하고 있습니다. 예를 들어, 비강주사제, 경피패치, 설하정 등 비침습적 전달 방법의 개발이 가속화되고 있으며, 기존의 정맥주사(IV) 및 경구용 약물을 대체할 수 있는 보다 편리한 대안을 제공하고 있습니다. 약리학적 개입과 인지행동치료(CBT) 및 생활습관 개선을 통합한 총체적 치료 접근법이 소비자 선호도를 형성하고 있는 점도 영향을 미치고 있습니다. 더 많은 여성들이 자신의 정신건강에 적극적일수록 효과적인 PPD 약물의 채택은 크게 증가할 것으로 예상됩니다.
북미가 시장을 주도하는 이유와 지역 역학은?
북미, 특히 미국은 강력한 의료 인프라, 높은 인식 수준, 강력한 제약 R&D 활동으로 산후 우울증 치료제 시장을 주도하고 있습니다. 이 지역은 혁신적인 의약품의 승인 및 상용화를 촉진하는 잘 확립된 규제 프레임워크의 혜택을 누리고 있습니다. 또한, Sage Therapeutics와 Biogen과 같은 업계 선도 기업의 존재는 의약품 개발의 빠른 발전에 기여하고 있습니다. 또한, 미국 식품의약국(FDA)은 새로운 PPD 치료제의 신속한 승인을 위해 적극적인 조치를 취하여 필요한 환자들에게 신속한 시장 접근을 보장하고 있습니다.
반면, 유럽은 임산부의 정신건강 증진을 위한 정부의 노력이 활발해지고, 의료서비스에 대한 접근성이 개선된 것이 그 배경입니다. 독일, 영국, 프랑스 등의 국가에서는 정신건강 치료를 보장하는 국가 의료 프로그램에 힘입어 PPD 약물 처방률이 꾸준히 상승하고 있습니다. 한편, 아시아태평양은 인식 제고, 의료비 지출 증가, 의약품 유통망 확대로 인해 유리한 시장으로 부상하고 있습니다. 그러나 아시아 및 중동 일부 국가에서는 정신건강을 둘러싼 문화적 편견이 시장 침투에 걸림돌로 작용하고 있으며, 이에 따라 집중적인 인식 개선과 정책 개혁의 필요성이 대두되고 있습니다.
산후 우울증 치료제 시장의 성장은 몇 가지 요인에 의해 발생합니다.
주요 촉진요인 중 하나는 기존 항우울제에 비해 빠른 완화를 제공하는 신경스테로이드 기반 약물의 발전으로, 최근 GABA 수용체 조절제의 획기적인 발전은 심각한 산후 우울증을 경험하는 여성들에게 절실히 필요한 대안을 제공했으며, 이러한 새로운 약물의 채택 증가로 이어졌습니다. 으로 이어졌습니다. 또한, 신약 개발에 인공지능(AI)을 통합함으로써 보다 효과적이고 표적화된 치료법 개발이 가속화되고 있으며, 부작용을 최소화하면서 약효를 향상시키고 있습니다.
시장 성장을 촉진하는 또 다른 중요한 요인은 여성 건강에 대한 투자가 증가하고 있다는 점입니다. 정부 및 민간 단체는 임산부 정신건강 프로그램에 많은 자금을 할당하고 있으며, 산후 우울증 치료제에 대한 접근성을 높이고 있습니다. 또한, 제약사들은 안전성 프로파일을 개선한 새로운 약물 제제를 찾기 위해 임상 연구 노력을 적극적으로 확대하고 있습니다. 또한, 디지털 의학 및 원격 정신의학이 도입되고 있는 것도 시장에 큰 영향을 미치고 있으며, 환자들에게 의료 전문가 및 약물 관리 서비스에 대한 더 나은 접근성을 제공하고 있습니다.
또한 소매점 및 온라인 약국 유통 채널이 확대됨에 따라 PPD 약품의 접근성이 향상되어 도시와 시골을 막론하고 환자들이 쉽게 치료받을 수 있게 되었습니다. 산후 우울증 치료제 시장은 기술, 치료, 소비자 주도적 요인이 결합하여 향후 몇 년간 지속적인 성장을 보일 것으로 예상되며, 규제 당국이 혁신적인 제약 솔루션의 신속한 승인을 지속적으로 지원하고 있습니다.
부문
유형(산후 불안, 산후 우울감, 산후 강박장애, 산후 외상 후 스트레스 장애, 산후 공황장애, 산후 정신병), 치료 유형(약물요법, 호르몬요법, 기타 치료 유형), 투여 경로(비경구 투여, 경구 투여, 기타 투여 경로), 유통 채널(병원 약국, 소매 약국, 기타 유통 채널)
조사 대상 기업 사례
AbbVie Inc.
Allergan plc
AstraZeneca plc
Bayer AG
Biogen Inc.
Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
H. Lundbeck A/S
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Pfizer Inc.
Sage Therapeutics, Inc.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Ltd.
Teva Pharmaceutical Industries Ltd.
AI 통합
Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 일반적인 LLM 및 업계 고유의 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
ksm
영문 목차
영문목차
Global Postpartum Depression Drugs Market to Reach US$1.4 Billion by 2030
The global market for Postpartum Depression Drugs estimated at US$894.9 Million in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Postpartum Anxiety, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$300.5 Million by the end of the analysis period. Growth in the Postpartum Blues segment is estimated at 5.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$243.8 Million While China is Forecast to Grow at 11.8% CAGR
The Postpartum Depression Drugs market in the U.S. is estimated at US$243.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$294.2 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.
What Are the Latest Innovations Reshaping the Postpartum Depression Treatment Landscape?
The postpartum depression (PPD) drugs market has seen a significant transformation in recent years, driven by advancements in pharmaceutical research and increased awareness of maternal mental health. Traditional antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have long been the standard of care. However, the recent approval of rapid-acting medications like brexanolone (Zulresso) and zuranolone has marked a paradigm shift in treatment approaches. Unlike conventional antidepressants, which take weeks to show effectiveness, these new medications provide relief within hours or days, addressing the urgent need for faster-acting solutions in severe cases of PPD.
Additionally, there is growing interest in the role of neurosteroid-based therapies, which target the gamma-aminobutyric acid (GABA) receptors, a mechanism that differs from traditional antidepressants. Researchers are also exploring personalized medicine approaches, leveraging genetic and biomarker-driven data to tailor drug treatments based on individual patient profiles. The increased use of telemedicine and digital health tools further enhances access to these innovative treatments, making PPD care more efficient and patient-centered.
How Are Market Trends and Consumer Awareness Shaping Demand?
The demand for postpartum depression drugs is rising globally, fueled by increasing recognition of maternal mental health issues and evolving healthcare policies. Governments and healthcare organizations worldwide are investing in awareness campaigns to reduce the stigma surrounding PPD and encourage affected individuals to seek medical intervention. The expansion of reimbursement policies for mental health treatments has also played a crucial role in driving prescription rates for PPD medications.
Furthermore, the pharmaceutical industry is witnessing a surge in research collaborations aimed at developing novel drug formulations. For instance, the push for non-invasive delivery methods such as nasal sprays, transdermal patches, and sublingual tablets is gaining momentum, offering more convenient alternatives to traditional intravenous (IV) or oral medications. The growing acceptance of holistic treatment approaches, which integrate pharmacological interventions with cognitive-behavioral therapy (CBT) and lifestyle modifications, is also shaping consumer preferences. As more women become proactive about their mental health, the adoption of effective PPD drugs is expected to rise significantly.
Why Is North America Leading the Market, and What Are the Regional Dynamics?
North America, particularly the United States, dominates the postpartum depression drugs market due to strong healthcare infrastructure, high awareness levels, and robust pharmaceutical research and development activities. The region benefits from a well-established regulatory framework that expedites the approval and commercialization of innovative drugs. The presence of key industry players, such as Sage Therapeutics and Biogen, has also contributed to rapid advancements in drug development. Additionally, the U.S. Food and Drug Administration (FDA) has taken proactive measures to fast-track the approval of novel PPD treatments, ensuring quicker market access for patients in need.
On the other hand, Europe follows closely behind, driven by increased government initiatives promoting maternal mental health and improved healthcare access. Countries such as Germany, the UK, and France have witnessed a steady rise in prescription rates for PPD drugs, supported by national healthcare programs that cover mental health treatments. Meanwhile, the Asia-Pacific region is emerging as a lucrative market due to rising awareness, increasing healthcare expenditure, and expanding pharmaceutical distribution networks. However, cultural stigmas surrounding mental health in several Asian and Middle Eastern countries continue to pose challenges to market penetration, highlighting the need for targeted awareness initiatives and policy reforms.
The Growth in the Postpartum Depression Drugs Market Is Driven by Several Factors
One of the key drivers is the advancement in neurosteroid-based therapeutics, which offer faster relief compared to traditional antidepressants. The recent breakthroughs in GABA receptor modulators have provided a much-needed alternative for women who experience severe postpartum depression, leading to increased adoption of these novel drugs. Furthermore, the integration of artificial intelligence (AI) in drug discovery is accelerating the development of more effective and targeted treatments, enhancing drug efficacy while minimizing side effects.
Another crucial factor fueling market growth is the increasing investment in women’s health initiatives. Governments and private organizations are allocating substantial funds toward maternal mental health programs, leading to greater accessibility to postpartum depression medications. Additionally, pharmaceutical companies are actively expanding their clinical research efforts to explore new drug formulations with improved safety profiles. The rising adoption of digital therapeutics and telepsychiatry is also significantly influencing the market, providing patients with better access to healthcare professionals and medication management services.
Moreover, the expansion of retail and online pharmacy distribution channels is streamlining the availability of PPD drugs, ensuring that patients in both urban and rural areas have better access to treatment. As regulatory agencies continue to support fast-track approvals for innovative drug solutions, the postpartum depression drugs market is expected to witness sustained growth in the coming years, driven by a convergence of technological, therapeutic, and consumer-driven factors.
SCOPE OF STUDY:
The report analyzes the Postpartum Depression Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder, Postpartum Psychosis); Treatment Type (Pharmacotherapy, Hormonal Therapy, Other Treatment Types); Administration Route (Parenteral Administration, Oral Administration, Other Administration Routes); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 41 Featured) -
AbbVie Inc.
Allergan plc
AstraZeneca plc
Bayer AG
Biogen Inc.
Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
H. Lundbeck A/S
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Pfizer Inc.
Sage Therapeutics, Inc.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Ltd.
Teva Pharmaceutical Industries Ltd.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Postpartum Depression Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Awareness of Postpartum Depression Drives Demand for Specialized Pharmaceutical Solutions
Rising Prevalence of Postpartum Depression among New Mothers Spurs Growth in the Market for Postpartum Depression Drugs
Regulatory Approvals of New Postpartum Depression Drugs Accelerate Market Expansion
Emergence of Novel Drug Classes for Postpartum Depression Strengthens the Business Case for Market Growth
Advancements in Personalized Medicine for Postpartum Depression Treatment Expands Addressable Market Opportunity
Growing Focus on Mental Health and Maternal Well-being Drives Adoption of Postpartum Depression Medications
Expanding Healthcare Access in Emerging Markets Increases the Reach of Postpartum Depression Drugs
Rising Investments in Womens Mental Health and Postpartum Care Enhances Market Opportunities for Pharmaceutical Companies
Increasing Recognition of Postpartum Depression as a Serious Health Concern Generates Demand for Effective Treatment Solutions
Development of Non-Pharmacological Treatments for Postpartum Depression Strengthens the Market Landscape
Integration of Digital Health Platforms for Postpartum Depression Management Expands Treatment Options
Impact of Telemedicine and Remote Monitoring on Postpartum Depression Treatment Propels Growth in Drug Adoption
Shift Towards Integrated Healthcare Solutions for Maternal Mental Health Drives Increased Drug Utilization
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Postpartum Depression Drugs Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Postpartum Depression Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Postpartum Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Postpartum Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Postpartum Anxiety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Postpartum Blues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Postpartum Blues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Postpartum Blues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Postpartum Obsessive-Compulsive Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Postpartum Obsessive-Compulsive Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Postpartum Obsessive-Compulsive Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Postpartum Post-Traumatic Stress Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Postpartum Post-Traumatic Stress Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Postpartum Post-Traumatic Stress Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Postpartum Panic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Postpartum Panic Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Postpartum Panic Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Postpartum Psychosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Postpartum Psychosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Postpartum Psychosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for Pharmacotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for Pharmacotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Hormonal Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 45: World Historic Review for Hormonal Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: World 15-Year Perspective for Hormonal Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 47: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 48: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 50: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: USA Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: USA 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: USA Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: USA 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 56: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: USA Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: USA 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 59: USA Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: USA Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: USA 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
CANADA
TABLE 62: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Canada 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 65: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Canada Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Canada 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 68: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Canada Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Canada 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 71: Canada Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Canada Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Canada 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
JAPAN
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 74: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Japan Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: Japan 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 77: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: Japan Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: Japan 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 80: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Japan Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Japan 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 83: Japan Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: Japan Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Japan 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
CHINA
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 86: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: China Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: China 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 89: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: China Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: China 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 92: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: China Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: China 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 95: China Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: China Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: China 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
EUROPE
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 98: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 99: Europe Historic Review for Postpartum Depression Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Europe 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 101: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Europe Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Europe 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 104: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Europe Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: Europe 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 107: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: Europe Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 109: Europe 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 110: Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: Europe Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 112: Europe 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
FRANCE
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 113: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 114: France Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 115: France 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 116: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: France Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 118: France 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 119: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 120: France Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 121: France 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 122: France Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: France Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 124: France 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
GERMANY
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 125: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 126: Germany Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 127: Germany 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 128: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Germany Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 130: Germany 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 131: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 132: Germany Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 133: Germany 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 134: Germany Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: Germany Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 136: Germany 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
ITALY
TABLE 137: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 138: Italy Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 139: Italy 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 140: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: Italy Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 142: Italy 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 143: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 144: Italy Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 145: Italy 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 146: Italy Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 147: Italy Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 148: Italy 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
UNITED KINGDOM
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 149: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 150: UK Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 151: UK 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 152: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: UK Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 154: UK 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 155: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 156: UK Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 157: UK 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 158: UK Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: UK Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 160: UK 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
SPAIN
TABLE 161: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 162: Spain Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 163: Spain 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 164: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 165: Spain Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 166: Spain 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 167: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 168: Spain Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 169: Spain 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 170: Spain Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: Spain Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 172: Spain 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
RUSSIA
TABLE 173: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 174: Russia Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 175: Russia 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 176: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 177: Russia Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 178: Russia 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 179: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 180: Russia Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 181: Russia 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 182: Russia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 183: Russia Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 184: Russia 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 186: Rest of Europe Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 187: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 189: Rest of Europe Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 190: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 192: Rest of Europe Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 193: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Europe Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 196: Rest of Europe 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 198: Asia-Pacific Historic Review for Postpartum Depression Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 199: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 201: Asia-Pacific Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 202: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 204: Asia-Pacific Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 205: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 207: Asia-Pacific Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 208: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 210: Asia-Pacific Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 211: Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
AUSTRALIA
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 212: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 213: Australia Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 214: Australia 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 215: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 216: Australia Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 217: Australia 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 218: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 219: Australia Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 220: Australia 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 221: Australia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 222: Australia Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 223: Australia 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
INDIA
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 224: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 225: India Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 226: India 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 227: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 228: India Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 229: India 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 230: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 231: India Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 232: India 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 233: India Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 234: India Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 235: India 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 236: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 237: South Korea Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 238: South Korea 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 239: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 240: South Korea Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 241: South Korea 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 242: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 243: South Korea Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 244: South Korea 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 245: South Korea Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 246: South Korea Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 247: South Korea 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 249: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 252: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 255: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 258: Rest of Asia-Pacific Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
LATIN AMERICA
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 260: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 261: Latin America Historic Review for Postpartum Depression Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 262: Latin America 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 263: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 264: Latin America Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 265: Latin America 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 266: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 267: Latin America Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 268: Latin America 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 269: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 270: Latin America Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 271: Latin America 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 272: Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 273: Latin America Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 274: Latin America 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 275: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 276: Argentina Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 277: Argentina 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 278: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 279: Argentina Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 280: Argentina 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 281: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 282: Argentina Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 283: Argentina 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 284: Argentina Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 285: Argentina Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 286: Argentina 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
BRAZIL
TABLE 287: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 288: Brazil Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 289: Brazil 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 290: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 291: Brazil Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 292: Brazil 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 293: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 294: Brazil Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 295: Brazil 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 296: Brazil Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 297: Brazil Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 298: Brazil 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
MEXICO
TABLE 299: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 300: Mexico Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 301: Mexico 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 302: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 303: Mexico Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 304: Mexico 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 305: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 306: Mexico Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 307: Mexico 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 308: Mexico Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 309: Mexico Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 310: Mexico 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 312: Rest of Latin America Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 313: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 315: Rest of Latin America Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 316: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 318: Rest of Latin America Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 319: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 321: Rest of Latin America Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 322: Rest of Latin America 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
MIDDLE EAST
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 323: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 324: Middle East Historic Review for Postpartum Depression Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 325: Middle East 15-Year Perspective for Postpartum Depression Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 326: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 327: Middle East Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 328: Middle East 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 329: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 330: Middle East Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 331: Middle East 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 332: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 333: Middle East Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 334: Middle East 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 335: Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 336: Middle East Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 337: Middle East 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
IRAN
TABLE 338: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 339: Iran Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 340: Iran 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 341: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 342: Iran Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 343: Iran 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 344: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 345: Iran Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 346: Iran 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 347: Iran Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 348: Iran Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 349: Iran 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
ISRAEL
TABLE 350: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 351: Israel Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 352: Israel 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 353: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 354: Israel Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 355: Israel 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 356: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 357: Israel Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 358: Israel 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 359: Israel Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 360: Israel Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 361: Israel 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 363: Saudi Arabia Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 364: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 366: Saudi Arabia Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 367: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 369: Saudi Arabia Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 370: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 372: Saudi Arabia Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 373: Saudi Arabia 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 374: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 375: UAE Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 376: UAE 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 377: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 378: UAE Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 379: UAE 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 380: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 381: UAE Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 382: UAE 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 383: UAE Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 384: UAE Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 385: UAE 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 387: Rest of Middle East Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 388: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 390: Rest of Middle East Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 391: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 393: Rest of Middle East Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 394: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 396: Rest of Middle East Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 397: Rest of Middle East 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
AFRICA
Postpartum Depression Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 398: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 399: Africa Historic Review for Postpartum Depression Drugs by Type - Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 400: Africa 15-Year Perspective for Postpartum Depression Drugs by Type - Percentage Breakdown of Value Sales for Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Panic Disorder and Postpartum Psychosis for the Years 2015, 2025 & 2030
TABLE 401: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 402: Africa Historic Review for Postpartum Depression Drugs by Administration Route - Parenteral Administration, Oral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 403: Africa 15-Year Perspective for Postpartum Depression Drugs by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration, Oral Administration and Other Administration Routes for the Years 2015, 2025 & 2030
TABLE 404: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 405: Africa Historic Review for Postpartum Depression Drugs by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 406: Africa 15-Year Perspective for Postpartum Depression Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels for the Years 2015, 2025 & 2030
TABLE 407: Africa Recent Past, Current & Future Analysis for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 408: Africa Historic Review for Postpartum Depression Drugs by Treatment Type - Pharmacotherapy, Hormonal Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 409: Africa 15-Year Perspective for Postpartum Depression Drugs by Treatment Type - Percentage Breakdown of Value Sales for Pharmacotherapy, Hormonal Therapy and Other Treatment Types for the Years 2015, 2025 & 2030